Prime Minister missteps, ongoing conflict between the U.S. and Iran, and climate change strikes around the world are big news stories this week.
If you were going to die, should you have the right to try experimental drugs that might save your life?
While some supporters want terminal patients to have access to any treatment that might help them, critics worry that unproven treatments might unfairly raise hopes for miracles.
- Sarah Karlin-Smith Health care reporter, Politico; @SarahKarlin
- Alison Bateman-House Co-chair of the NYU Langone Health Working Group on Compassionate Use and Pre-Approval Access. Assistant Professor in the Division of Medical Ethics at New York University Langone Medical Center. @ABatemanHouse
- Robert Graboyes Senior Research Fellow and Health Care Scholar at the Mercatus Center at George Mason University. @Robert_Graboyes
- Dr. Kelly Shanahan Medical director of METUp, a patient advocacy group for those with metastatic cancer. Former OB/GYN, currently living with Stage IV breast cancer. @stage4kelly
- Michael Becker President and founder of MDB Communications LLC. Author of "A Walk with Purpose," about his time as a biotechnology executive and his Stage IV head & neck cancer diagnosis. @Becker_MichaelD
Most Recent Shows
The president threatens action against California. His former campaign manager doesn't cooperate with Congress.
Millennials might be accused of killing a lot of industries. The plant business isn't one of them.
We explore one author's quest for truth in an increasingly fake world.